Pricing Log in Create free account

City Therapeutics, Inc (CTY) vs Monte Rosa Therapeutics, Inc. (GLUE)

City Therapeutics, Inc and Monte Rosa Therapeutics, Inc. are both Biotechnology companies. City Therapeutics, Inc and Monte Rosa Therapeutics, Inc. are of similar size ($882.9M and $874.5M).

Valuation

Metric CTY GLUE Biotechnology median
P/E — n/m 10.60
P/S — 15.18 9.40
P/B — 2.15 2.13
Price to free cash flow — n/m 25.18
EV/EBITDA — n/m 0.66
EV/Sales — 6.97 9.02
Earnings yield — (13.35%) (32.88%)
Free cash flow yield — (16.33%) (23.13%)

Profitability

Metric CTY GLUE Biotechnology median
Gross margin — 100.00% 68.51%
Operating margin — (214.46%) 0.00%
Net margin — (186.24%) 0.00%
Free cash flow margin — (247.98%) 0.00%
Return on equity — (35.30%) (51.96%)
Return on assets — (22.63%) (46.06%)
Return on invested capital — 0.00% 0.00%

Growth

Metric CTY GLUE Biotechnology median
Revenue growth (TTM) — (61.26%) 6.76%
EPS growth (last fiscal year) — 53.06% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CTY GLUE Biotechnology median
Debt to equity — 0.00 0.00
Current ratio — 10.32 4.97
Net debt to EBITDA — 8.22 1.01

Dividend

Metric CTY GLUE Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CTY GLUE Biotechnology median
Market cap 882.88m 874.46m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack